Brokerages Set United States Antimony Co. (NYSE:UAMY) Price Target at $3.38

Key Points

• United States Antimony Co. received a consensus rating of "Buy" from five research firms, with four analysts giving it a buy rating and one a strong buy rating.
• The average 1-year price objective among analysts for the stock is $3.3750, with some analysts setting targets as high as $5.00.
• The company's stock has risen 2.5%, and it currently has a market cap of $596.37 million along with a debt-to-equity ratio of 0.01.

United States Antimony Co. (NYSE:UAMY - Get Free Report) has been given an average rating of "Buy" by the five analysts that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $3.3750.

UAMY has been the subject of several research reports. Wall Street Zen downgraded shares of United States Antimony from a "hold" rating to a "sell" rating in a research report on Thursday, May 15th. HC Wainwright reiterated a "buy" rating and issued a $4.50 price target on shares of United States Antimony in a research report on Wednesday, August 13th. Finally, D. Boral Capital reiterated a "buy" rating and issued a $5.00 price target on shares of United States Antimony in a research report on Thursday, August 14th.

United States Antimony Stock Performance

UAMY stock traded down $0.02 during mid-day trading on Wednesday, hitting $4.55. 5,754,012 shares of the company were exchanged, compared to its average volume of 4,075,851. The business has a 50 day simple moving average of $3.40 and a 200-day simple moving average of $2.78. The company has a current ratio of 6.24, a quick ratio of 5.84 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $565.69 million, a PE ratio of -113.75 and a beta of 0.05. United States Antimony has a 1-year low of $0.49 and a 1-year high of $5.13.

Institutional Investors Weigh In On United States Antimony

Hedge funds and other institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in United States Antimony during the second quarter valued at approximately $33,000. Cetera Investment Advisers acquired a new position in United States Antimony during the fourth quarter valued at approximately $40,000. ProShare Advisors LLC acquired a new position in United States Antimony during the second quarter valued at approximately $41,000. Penbrook Management LLC bought a new stake in shares of United States Antimony during the second quarter worth $44,000. Finally, Tower Research Capital LLC TRC grew its stake in shares of United States Antimony by 2,205.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 26,716 shares of the company's stock worth $47,000 after buying an additional 25,557 shares during the last quarter. 9.49% of the stock is currently owned by institutional investors and hedge funds.

About United States Antimony

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.